Condom gap in Africa: evidence from donor agencies and key informants

BMJ. 2001 July 21; 323(7305): 139.

PMCID: PMC34724

Condom gap in Africa: evidence from donor agencies and key informants

James D Shelton, senior medical scientist^a and Beverly Johnston, senior researcher^b

^aCenter for Population, Health and Nutrition, US Agency for International Development, Washington, DC 20523, USA, ^bFutures Group International, Population, Health and Nutrition Information Project, 600 13th Street, NW, Washington, DC 20005, USA

Contributed by

Contributors: JDS conceived the analysis, directed the overall data collection, and led writing the paper. BJ had primary responsibility for collecting and compiling data and helped write the paper. JDS is the guarantor.

Correspondence to: J D Shelton Jshelton/at/USAID.gov

Accepted June 13, 2001.

See "A global health fund: a leap of faith?" on page 152.

See editorial "Poverty reduction strategy papers " on page 120.

This article has been cited by other articles in PMC.

Public discussions on combating HIV in Africa seem to be focusing on antiretroviral drugs rather than condoms, which are the mainstay of prevention.¹ In sub-Saharan Africa most condoms are bought with funds from donors, although a few countries (such as South Africa and Botswana) buy them from national funds. We assessed provision of condoms in these countries.

Methods and results

We obtained data from UNFPA (the United Nations agency responsible for providing condoms) on condoms paid for by donors and further refined it with information from United States Agency for International Development's commodity tracking system. We also sought data from about 12 key informants knowledgeable on condom provision in Africa.

Provision of condoms by donors remained surprisingly constant (400-500 million per year) over the past five years. The numbers fell from just over 600 million in 1995 to about 340 million in 1998 before rising again to just over 500 million in 1999. In addition, by 1999 roughly 210 million condoms were purchased by countries' own funds. This amounts to a total of about 724 million condoms or only 4.6 condoms per man aged 15-59 years in sub-Saharan Africa.

Level of provision varied widely. Provision in the six countries with highest levels (Botswana, South Africa, Zimbabwe, Togo, Congo, and Kenya) averaged about 17 condoms per man aged 15-59. If that level of provision were replicated for all 156 million sub-Saharan African men, annual provision would be 2.65 billion. This corresponds to a “condom gap” of roughly 1.9 billion a year (figure).

Comment

We found that the overall provision of condoms was 4.6 per man per year, which seems low. Another 1.9 billion condoms need to be provided a year for all countries to equal the level of provision of the six highest providing countries.

We may have overestimated the condom gap since we omitted the commercial sector and probably missed some national government and donor support. However, given the resource poor environments in Africa, we believe our rough estimate missed only a small proportion of condoms. The true gap could be considerably larger than our estimate because the need may be larger than 17 condoms per man and the population in Africa is still growing.

How much would it cost to close the 1.9 billion condom gap for sub-Saharan Africa? At the international price of $0.025 per condom, the annual cost would be only $47.5m (£34m). However, as with drugs to treat HIV, the commodity costs are only the beginning. Service delivery costs (including promotion) are a greater challenge. Nevertheless, effective models for delivery are known and much infrastructure is in place or can be scaled up through existing successful mechanisms such as condom social marketing and clinics.²

But health programming of any sort requires concerted effort and resources. Finding ways to promote condom use and other prevention among high transmitting people is particularly important. Experience in Thailand shows such an approach can greatly reduce sexually transmitted infection and HIV.³

Relative to the enormity of the HIV/AIDS pandemic in Africa, providing condoms is cheap and cost effective. All aspects of HIV control are important, but a first priority must be prevention.

Figure

Condom procurement in sub-Saharan African countries in 1999. Horizontal line represents average procurement of top 6 countries

Acknowledgments

The views expressed are solely those of the authors and not necessarily those of USAID. We thank Steve Hawkins for help with data and a critique of the paper and John Stover, John Ross, and Randy Bulato for technical insights.

Notes

See also Editorial by Verheul and Rowson and Education and debate p 152

Footnotes

Funding: USAID.

Competing interests: None declared.

References

1. Sidley P. South African court battle damages drug industry's image. BMJ. 2001;322:635. [PMC free article] [PubMed]

2. Gardner R, Blackburn RD, Upadhyay UD. Closing the condom gap. Baltimore: Johns Hopkins University School of Public Health, Population Information Program; 1999. . (Population reports, series H, No 9.)

3. Hanenberg RS, Rojanapithayakorn W, Kunasol P, Sokal D. Impact of Thailand's HIV-control programme as indicated by the decline in sexually transmitted diseases. Lancet. 1994;344:243–245. [PubMed]

Articles from BMJ : British Medical Journal are provided here courtesy of
BMJ Publishing Group